05:14 , Jun 26, 2019 |  BC Extra  |  Financial News

Spain’s Sanifit heads to Phase III with €72.2M in new funding

With €72.2 million ($82.1 million) in fresh cash to fund a Phase III study of its lead candidate to treat a rare vascular calcification disorder, Sanifit is looking ahead to additional Phase IIb trial results...
20:25 , Oct 5, 2018 |  BC Week In Review  |  Financial News

Minoryx raises €21M series B, advances MIN-102

Minoryx Therapeutics S.L. (Mataro, Spain) raised €21.3 million ($24.7 million) on Sept. 26 in a series B round led by Fund+. SFPI, S.R.I.W. and Sambrinvest also participated as did existing investors Ysios Capital, Kurma Partners,...
21:31 , May 10, 2018 |  BC Innovations  |  Emerging Company Profile

Abac’s precision platform

Abac Therapeutics S.A. is taking a precision approach to treat bacterial infections that could avoid the development of drug resistance that plagues broad-spectrum antibiotics. The company’s PasNas platform uses phenotypic and in vitro assays to...
20:04 , Feb 16, 2018 |  BioCentury  |  Finance

Quark gets specific

Abac Therapeutics S.A.’s targeted approach to antibiotic development led Quark Venture to join the company’s €16 million ($19.6 million) series A round, which will enable it to bring its lead program into the clinic. Pontifax...
19:12 , Feb 16, 2018 |  BC Week In Review  |  Financial News

Abac raises €16M series A

Abac Therapeutics S.A. (Barcelona, Spain) raised €16 million ($19.6 million) on Feb. 15 in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital Risc and Debiopharm Innovation Fund participated,...
22:21 , Feb 15, 2018 |  BC Extra  |  Financial News

Pontifax leads Abac’s €16M series A round

Abac Therapeutics S.A. (Barcelona, Spain) raised €16 million ($19.6 million) in a series A round led by Pontifax. New investors Global Health Science Fund, Caixa Capital Risc and Debiopharm Innovation Fund participated, as did existing...
07:00 , Apr 18, 2016 |  BC Week In Review  |  Financial News

Stat-Diagnostica and Innovation completes venture financing

Stat-Diagnostica and Innovation , Barcelona, Spain   Business: Diagnostic   Date completed: 2016-04-11   Type: Venture financing   Raised: EUR25 million ($28.4 million)   Investors: Gilde Healthcare Partners; Kurma Partners; Ysios Capital Partners; Idinvest Partners;...
08:00 , Jan 18, 2016 |  BC Week In Review  |  Financial News

Aelix Therapeutics completes venture financing

Aelix Therapeutics S.L. , Barcelona, Spain   Business: Infectious   Date completed: 2016-01-11   Type: Venture financing   Raised: EUR11.5 million ($12.5 million)   Investors: Ysios Capital Partners; Johnson & Johnson Development Corp.; Caixa Capital...
02:45 , Jan 12, 2016 |  BC Extra  |  Financial News

Aelix raises EUR 11.5M in series A

HIV vaccine developer Aelix Therapeutics S.L. (Barcelona, Spain) raised EUR 11.5 million ($12.5 million) in a series A round led by Ysios Capital. The Johnson & Johnson Innovation-JJDC venture arm of Johnson & Johnson (NYSE:JNJ)...
07:00 , Oct 19, 2015 |  BC Week In Review  |  Financial News

Minoryx completes venture financing

Minoryx Therapeutics S.L. , Mataro, Spain   Business: Endocrine/Metabolic, Neurology   Date completed: 2010-10-14   Type: Venture financing   Raised: EUR19.4 million ($22.1 million)   Investors: Ysios Capital Partners; Kurma Partners; Roche Venture Fund; Idinvest...